These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 23097134)
21. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells. Song N; Boku S; Nakagawa S; Kato A; Toda H; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Koyama T Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):183-9. PubMed ID: 22484386 [TBL] [Abstract][Full Text] [Related]
22. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Kaminskyy VO; Surova OV; Vaculova A; Zhivotovsky B Carcinogenesis; 2011 Oct; 32(10):1450-8. PubMed ID: 21771726 [TBL] [Abstract][Full Text] [Related]
23. Valproate Attenuates Endoplasmic Reticulum Stress-Induced Apoptosis in SH-SY5Y Cells via the AKT/GSK3β Signaling Pathway. Li Z; Wu F; Zhang X; Chai Y; Chen D; Yang Y; Xu K; Yin J; Li R; Shi H; Wang Z; Li X; Xiao J; Zhang H Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208696 [TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472 [TBL] [Abstract][Full Text] [Related]
25. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431 [TBL] [Abstract][Full Text] [Related]
26. Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma. Archer CR; Koomoa DL; Mitsunaga EM; Clerc J; Shimizu M; Kaiser M; Schellenberg B; Dudler R; Bachmann AS Biochem Pharmacol; 2010 Jul; 80(2):170-8. PubMed ID: 20362557 [TBL] [Abstract][Full Text] [Related]
27. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways. Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087 [TBL] [Abstract][Full Text] [Related]
28. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Pathil A; Armeanu S; Venturelli S; Mascagni P; Weiss TS; Gregor M; Lauer UM; Bitzer M Hepatology; 2006 Mar; 43(3):425-34. PubMed ID: 16583461 [TBL] [Abstract][Full Text] [Related]
29. Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine. Zhang YX; Yu SB; Ou-Yang JP; Xia D; Wang M; Li JR Acta Pharmacol Sin; 2005 Nov; 26(11):1365-72. PubMed ID: 16225760 [TBL] [Abstract][Full Text] [Related]
30. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. Jasek E; Lis GJ; Jasinska M; Jurkowska H; Litwin JA Anticancer Res; 2012 Jul; 32(7):2791-9. PubMed ID: 22753739 [TBL] [Abstract][Full Text] [Related]
31. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors. Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083 [TBL] [Abstract][Full Text] [Related]
33. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
35. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma. Eslin D; Sankpal UT; Lee C; Sutphin RM; Maliakal P; Currier E; Sholler G; Khan M; Basha R Mol Carcinog; 2013 May; 52(5):377-86. PubMed ID: 22213339 [TBL] [Abstract][Full Text] [Related]
36. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113 [TBL] [Abstract][Full Text] [Related]
37. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro. Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363 [TBL] [Abstract][Full Text] [Related]
38. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells. Iwata S; Saito T; Ito Y; Kamakura M; Gotoh K; Kawada J; Nishiyama Y; Kimura H Cancer Sci; 2012 Feb; 103(2):375-81. PubMed ID: 22017376 [TBL] [Abstract][Full Text] [Related]
39. [Inhibitory effect of valproic acid on xenografted Kasumi-1 tumor growth in nude mouse and its mechanism]. Liu P; Tian X; Shi GR; Jiang FY; Liu BQ; Zhang ZH; Zhao L; Yan LN; Liang ZQ; Hao CL Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):458-62. PubMed ID: 22213865 [TBL] [Abstract][Full Text] [Related]
40. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells. Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]